We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Camtek Ltd | NASDAQ:CAMT | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-2.62 | -2.86% | 89.00 | 84.78 | 90.00 | 94.90 | 89.31 | 93.50 | 409,701 | 01:00:00 |
CAMTEK LTD.
(Registrant) By: /s/ Moshe Eisenberg —————————————— Moshe Eisenberg, Chief Financial Officer |
Exhibit
Number
|
Description of Exhibit
|
|
|
101
|
The following financial information from Camtek Ltd.’s Report on Form 6-K, formatted in XBRL (eXtensible Business Reporting Language): (i) Unaudited interim condensed consolidated balance sheets on June 30, 2023 and December 31, 2022; (ii) Unaudited interim condensed consolidated statements of operations for the six months ended June 30, 2023 and 2022 and the year ended December 31, 2022; (iii) Unaudited interim condensed consolidated statements of changes in shareholders’ equity for the six months ended June 30, 2023 and 2022 and the year ended December 31, 2022; (iv) Unaudited interim condensed consolidated statements of cash flows for the six months ended June 30, 2023 and 2022 and the year ended December 31, 2022; and (v) notes to the Unaudited interim condensed consolidated financial statements.
|
Camtek Ltd. and its Subsidiaries
Interim Condensed Consolidated Financial Statements As of June 30, 2023 (Unaudited) |
Interim Unaudited Condensed Consolidated Financial Statements as at June 30, 2023
Page | |
F-3 | |
F-4 to F-5 | |
F-6 | |
F-7 to F-8 | |
F-9 to F-16 |
F - 2
Camtek Ltd. and its Subsidiaries
June 30,
|
December 31,
|
||||||||||
2023
|
2022
|
||||||||||
Note
|
U.S. Dollars (in thousands)
|
||||||||||
Assets
|
|||||||||||
Current assets
|
|||||||||||
Cash and cash equivalents
|
4A
|
|
|
|
|||||||
Short-term deposits
|
|
|
|||||||||
Trade accounts receivable
|
|
|
|||||||||
Inventories
|
4B
|
|
|
|
|||||||
Other current assets
|
4C
|
|
|
|
|||||||
Total current assets
|
|
|
|||||||||
Long term deposits
|
|
|
|||||||||
Long term inventory
|
4B
|
|
|
|
|||||||
Deferred tax assets
|
|
|
|||||||||
Other assets
|
|
|
|||||||||
Property, plant and equipment, net
|
4D
|
|
|
|
|||||||
Intangible assets, net
|
4E
|
|
|
|
|||||||
Total non-current assets
|
|
|
|||||||||
Total assets
|
|
|
|||||||||
Liabilities and shareholders’ equity
|
|||||||||||
Current liabilities
|
|||||||||||
Trade accounts payable
|
|
|
|||||||||
Other current liabilities
|
4F
|
|
|
|
|||||||
Total current liabilities
|
|
|
|||||||||
Long term liabilities
|
|||||||||||
Other long-term liabilities
|
|
|
|||||||||
Convertible notes
|
4G |
|
|
||||||||
|
|
||||||||||
Total liabilities
|
|
|
|||||||||
Shareholders’ equity
|
|||||||||||
Ordinary shares NIS
|
|||||||||||
|
|||||||||||
|
3
|
|
|
||||||||
Additional paid-in capital
|
|
|
|||||||||
Retained earnings
|
|
|
|||||||||
|
|
||||||||||
Treasury stock, at cost (
|
(
|
)
|
(
|
)
|
|||||||
Total shareholders' equity
|
|
|
|||||||||
Total liabilities and shareholders' equity
|
|
|
F - 3
Camtek Ltd. and its Subsidiaries
Six months ended
June 30,
|
Year ended
December 31,
|
||||||||||||||
2023
|
2022
|
2022
|
|||||||||||||
Note
|
U.S. dollars
|
U.S. dollars
|
|||||||||||||
Revenues
|
|
|
|
||||||||||||
Cost of revenues
|
|
|
|
||||||||||||
Gross profit
|
|
|
|
||||||||||||
Research and development costs
|
|
|
|
||||||||||||
Selling, general and
administrative expenses |
5A
|
|
|
|
|||||||||||
|
|
|
|||||||||||||
Operating income
|
|
|
|
||||||||||||
Financial income, net
|
5B
|
|
|
|
|
||||||||||
Income before income taxes
|
|
|
|
||||||||||||
Income tax expense
|
(
|
)
|
(
|
)
|
(
|
)
|
|||||||||
Net income
|
|
|
|
F - 4
Camtek Ltd. and its Subsidiaries
Six months ended
June 30,
|
Year ended
December 31,
|
||||||||||||||
2023
|
2022
|
2022
|
|||||||||||||
Note
|
U.S. dollars
|
U.S. dollars
|
|||||||||||||
Basic net earnings per share
|
|
|
|
||||||||||||
Diluted net earnings per share
|
|
|
|
||||||||||||
Weighted average number of ordinary shares outstanding
(in thousands):
|
|||||||||||||||
Basic
|
|
|
|
||||||||||||
Diluted
|
|
|
|
F - 5
Camtek Ltd. and its Subsidiaries
Interim Unaudited Condensed Consolidated Statements of Shareholders’ Equity
Ordinary Shares
|
Number of
|
Additional
|
Total
|
|||||||||||||||||||||||||
NIS 0.01 par value
|
Treasury
|
Treasury
|
paid-in
|
Retained
|
shareholders'
|
|||||||||||||||||||||||
Number of
|
U.S. Dollars
|
Shares
|
Shares
|
earnings
|
earnings
|
equity
|
||||||||||||||||||||||
Shares Issued
|
(in thousands)
|
U.S. Dollars (in thousands)
|
||||||||||||||||||||||||||
Balances at
|
||||||||||||||||||||||||||||
December 31, 2021
|
|
|
(
|
)
|
(
|
)
|
|
|
|
|||||||||||||||||||
Share-based
|
||||||||||||||||||||||||||||
compensation
|
||||||||||||||||||||||||||||
expense
|
-
|
|
-
|
|
|
|
|
|||||||||||||||||||||
Exercise of share
|
||||||||||||||||||||||||||||
options and RSUs
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Net income
|
-
|
|
-
|
|
|
|
|
|||||||||||||||||||||
Balances at
|
||||||||||||||||||||||||||||
June 30, 2022
|
|
|
(
|
)
|
(
|
)
|
|
|
|
|||||||||||||||||||
Share-based
|
||||||||||||||||||||||||||||
compensation
|
||||||||||||||||||||||||||||
expense
|
-
|
|
-
|
|
|
|
|
|||||||||||||||||||||
Exercise of share
|
||||||||||||||||||||||||||||
options and RSUs
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Net income
|
-
|
|
-
|
|
|
|
|
|||||||||||||||||||||
Balances at
|
||||||||||||||||||||||||||||
December 31, 2022
|
|
|
(
|
)
|
(
|
)
|
|
|
|
|||||||||||||||||||
Share-based
|
||||||||||||||||||||||||||||
compensation
|
||||||||||||||||||||||||||||
expense
|
-
|
|
-
|
|
|
|
|
|||||||||||||||||||||
Exercise of share
|
||||||||||||||||||||||||||||
options and RSUs
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Net income
|
-
|
|
-
|
|
|
|
|
|||||||||||||||||||||
Balances at
|
||||||||||||||||||||||||||||
June 30, 2023
|
|
|
(
|
)
|
(
|
)
|
|
|
|
F - 6
Camtek Ltd. and its Subsidiaries
Six months ended
June 30,
|
Year ended
December 31,
|
|||||||||||
2023
|
2022
|
2022
|
||||||||||
U.S. dollars
|
U.S. dollars
|
|||||||||||
Cash flows from operating activities:
|
||||||||||||
Net income
|
|
|
|
|||||||||
Adjustments to reconcile net income to net
|
||||||||||||
cash provided by operating activities:
|
||||||||||||
Depreciation and amortization
|
|
|
|
|||||||||
Deferred tax expense
|
|
|
(
|
)
|
||||||||
Amortization of debt issuance costs
|
|
|
|
|||||||||
Loss on disposal of fixed assets
|
|
|
|
|||||||||
Share based compensation expense
|
|
|
|
|||||||||
Change in provision for doubtful debts
|
|
|
(
|
)
|
||||||||
Changes in operating assets and liabilities:
|
||||||||||||
Trade accounts receivable
|
|
(
|
)
|
(
|
)
|
|||||||
Inventories
|
|
(
|
)
|
(
|
)
|
|||||||
Due from related parties
|
|
(
|
)
|
|
||||||||
Other assets
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Trade accounts payable
|
(
|
)
|
|
(
|
)
|
|||||||
Other current liabilities
|
(
|
)
|
(
|
)
|
|
|||||||
Net cash provided by operating activities
|
|
|
|
|||||||||
Cash flows from investing activities:
|
||||||||||||
Redemption (investment) of short-term deposits
|
|
(
|
)
|
(
|
)
|
|||||||
Investment of long-term deposits
|
|
(
|
)
|
(
|
)
|
|||||||
Purchase of fixed assets
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Purchase of intangible assets
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Net cash provided by (used in) investing activities
|
|
(
|
)
|
(
|
)
|
Cash flows from financing activities:
|
||||||||||||
Proceeds from exercise of share options
|
|
|
|
|||||||||
Net cash provided by financing activities
|
|
|
|
|||||||||
Effect of change in exchange rate on cash and cash equivalents
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Net increase (decrease) in cash and cash equivalents
|
|
(
|
)
|
(
|
)
|
|||||||
Cash and cash equivalents at beginning of the period
|
|
|
|
|||||||||
Cash and cash equivalents at end of the period
|
|
|
|
F - 7
Camtek Ltd. and its Subsidiaries
Six months ended
June 30,
|
Year ended
December 31,
|
|||||||||||
2023
|
2022
|
2022
|
||||||||||
U.S. dollars
|
U.S. dollars
|
|||||||||||
Supplementary cash flows information:
|
||||||||||||
Income taxes paid
|
|
|
|
|||||||||
Interest received
|
|
|
|
|||||||||
Lease payments
|
|
|
|
|||||||||
Non-cash transactions:
|
||||||||||||
Fixed assets purchased with supplier credit
|
|
|
|
The accompanying notes are an integral part of these interim unaudited condensed consolidated financial statements.
F - 8
Camtek Ltd. and its Subsidiaries
Notes to the Interim Unaudited Condensed Consolidated Financial Statements
A. |
Camtek Ltd. (“Camtek” or the “Company”), an Israeli corporation, is jointly controlled
|
F - 9
Camtek Ltd. and its Subsidiaries
Notes to the Interim Unaudited Condensed Consolidated Financial Statements
(Amounts in thousands, except per share data)
F - 10
Camtek Ltd. and its Subsidiaries
Notes to the Interim Unaudited Condensed Consolidated Financial Statements
(Amounts in thousands, except per share data)
The total share-based compensation expense amounted to $
F - 11
Camtek Ltd. and its Subsidiaries
Notes to the Interim Unaudited Condensed Consolidated Financial Statements
(Amounts in thousands, except per share data)
June 30,
|
December 31,
|
|||||||
2023
|
2022
|
|||||||
U.S. Dollars (in thousands)
|
||||||||
US Dollars
|
|
|
||||||
New Israeli Shekels
|
|
|
||||||
Other currencies
|
|
|
||||||
|
|
June 30,
|
December 31,
|
|||||||
2023
|
2022
|
|||||||
U.S. Dollars (in thousands)
|
||||||||
Components
|
|
|
||||||
Work in process
|
|
|
||||||
Finished products (including systems at customer locations not yet sold)
|
|
|
||||||
|
|
June 30,
|
December 31,
|
|||||||
2023
|
2022
|
|||||||
U.S. Dollars (in thousands)
|
||||||||
Current assets
|
61,207
|
|
||||||
Long-term assets
|
|
|
||||||
|
|
F - 12
Camtek Ltd. and its Subsidiaries
Notes to the Interim Unaudited Condensed Consolidated Financial Statements
(Amounts in thousands, except per share data)
June 30,
|
December 31,
|
|||||||
2023
|
2022
|
|||||||
U.S. Dollars (in thousands)
|
||||||||
Interest receivable
|
|
|
||||||
Prepaid expenses
|
|
|
||||||
Due from Government institutions
|
|
|
||||||
Other
|
|
|
||||||
|
|
June 30,
|
December 31,
|
|||||||
2023
|
2022
|
|||||||
U.S. Dollars (in thousands)
|
||||||||
Land
|
|
|
||||||
Building
|
|
|
||||||
Machinery and equipment
|
|
|
||||||
Office furniture and equipment
|
|
|
||||||
Computer equipment and software
|
|
|
||||||
Automobiles
|
|
|
||||||
Leasehold improvements
|
|
|
||||||
Right of use assets
|
|
|
||||||
|
|
|||||||
Less accumulated depreciation
|
|
|
||||||
|
|
F - 13
Camtek Ltd. and its Subsidiaries
Notes to the Interim Unaudited Condensed Consolidated Financial Statements
(Amounts in thousands, except per share data)
Note 4 - Supplementary Financial Statements Information (cont’d)
June 30,
|
December 31,
|
|||||||
2023
|
2022
|
|||||||
U.S. Dollars (in thousands)
|
||||||||
Patent registration costs
|
|
|
||||||
Accumulated amortization and impairment
|
|
|
||||||
Total intangible assets, net
|
|
|
June 30,
|
December 31,
|
|||||||
2023
|
2022
|
|||||||
U.S. Dollars (in thousands)
|
||||||||
Commissions
|
|
|
||||||
Advances from customers and deferred revenues
|
|
|
||||||
Accrued employee compensation and related benefits
|
|
|
||||||
Accrued warranty costs (1)
|
|
|
||||||
Government institutions and income tax payable
|
|
|
||||||
Accrued expenses
|
|
|
||||||
Operating lease obligations
|
|
|
||||||
|
|
|
June 30,
|
December 31,
|
|||||||
2023
|
2022
|
|||||||
U.S. Dollars (in thousands)
|
||||||||
Beginning of year
|
|
|
||||||
Accruals
|
|
|
||||||
Usage
|
(
|
)
|
(
|
)
|
||||
Balance at end of year
|
|
|
F - 14
Camtek Ltd. and its Subsidiaries
Notes to the Interim Unaudited Condensed Consolidated Financial Statements
(Amounts in thousands, except per share data)
Note 4 - Supplementary Financial Statements Information (cont’d)
June 30,
|
December 31,
|
|||||||
2023
|
2022
|
|||||||
U.S. Dollars (in thousands)
|
||||||||
Liability:
|
||||||||
Principle:
|
|
|
||||||
Unamortized issuance costs
|
|
|
||||||
Net carrying amount
|
|
|
F - 15
Camtek Ltd. and its Subsidiaries
Notes to the Interim Unaudited Condensed Consolidated Financial Statements
(Amounts in thousands, except per share data)
Note 5 - Statements of Operations
A.
|
Selling, general and administrative expenses
|
Six months ended
June 30,
|
Year ended
December 31,
|
|||||||||||
2023
|
2022
|
2022
|
||||||||||
U.S. Dollars (in thousands)
|
||||||||||||
Selling (1)
|
|
|
|
|||||||||
General and administrative
|
|
|
|
|||||||||
|
|
|
||||||||||
(1) Including shipping and handling costs
|
|
|
|
Six months ended
June 30,
|
Year ended
December 31,
|
|||||||||||
2023
|
2022
|
2022
|
||||||||||
U.S. Dollars (in thousands)
|
||||||||||||
Interest income
|
|
|
|
|||||||||
Amortization of issuance costs of convertible notes
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Other, net (1)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
|
|
||||||||||
(1) Including foreign currency expense resulting from transactions not denominated in U.S. Dollars
|
(
|
)
|
(
|
)
|
(
|
)
|
A. |
Operating Results
|
Six Months Ended June 30,
|
||||||||
2023
|
2022
|
|||||||
Revenues
|
100.0
|
%
|
100.0
|
%
|
||||
Cost of revenues
|
52.9
|
%
|
48.9
|
%
|
||||
Gross profit
|
47.1
|
%
|
51.1
|
%
|
||||
Operating expenses:
|
||||||||
Research and development, net
|
10.7
|
%
|
9.7
|
%
|
||||
Selling, general and administrative expenses
|
16.4
|
%
|
15.6
|
%
|
||||
Total operating expenses
|
27.2
|
%
|
25.3
|
%
|
||||
Operating income
|
19.9
|
%
|
25.8
|
%
|
||||
Financial income, net
|
7.4
|
%
|
0.5
|
%
|
||||
Income tax (expenses) benefit
|
(2.9
|
)%
|
(2.4
|
)%
|
||||
Net income
|
24.5
|
%
|
24.0
|
%
|
B.
|
Liquidity
and Capital Resources
|
Document and Entity Information |
6 Months Ended |
---|---|
Jun. 30, 2023 | |
Document And Entity [Abstract] | |
Entity Registrant Name | CAMTEK LTD |
Entity Central Index Key | 0001109138 |
Current Fiscal Year End Date | --12-31 |
Document Type | 6-K |
Amendment Flag | false |
Document Period End Date | Jun. 30, 2023 |
Document Fiscal Period Focus | Q2 |
Document Fiscal Year Focus | 2023 |
Entity Address, Address Line One | Ramat Gavriel Industrial Zone |
Entity Address, Address Line Two | P.O. Box 544 |
Entity Address, Address Line Three | Migdal Haemek |
Entity Address Country | IL |
Entity Address, Postal Zip Code | 23150 |
Interim Unaudited Condensed Consolidated Balance Sheets (Parenthetical) - ₪ / shares |
Jun. 30, 2023 |
Dec. 31, 2022 |
---|---|---|
Statement of Financial Position [Abstract] | ||
Common Stock, par value per share | ₪ 0.01 | ₪ 0.01 |
Common Stock, shares authorized | 100,000,000 | 100,000,000 |
Common Stock, shares issued | 46,811,504 | 46,505,318 |
Common Stock, shares outstanding | 44,719,128 | 44,412,942 |
Treasury Stock, Common, Shares | 2,092,376 | 2,092,376 |
Interim Unaudited Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands |
6 Months Ended | 12 Months Ended | |
---|---|---|---|
Jun. 30, 2023 |
Jun. 30, 2022 |
Dec. 31, 2022 |
|
Income Statement [Abstract] | |||
Revenues | $ 146,215 | $ 156,744 | $ 320,909 |
Cost of revenues | 77,378 | 76,693 | 161,053 |
Gross profit | 68,837 | 80,051 | 159,856 |
Research and development costs | 15,672 | 15,199 | 28,859 |
Selling, general and administrative expenses | 24,037 | 24,451 | 49,499 |
Total operating expenses | 39,709 | 39,650 | 78,358 |
Operating income | 29,128 | 40,401 | 81,498 |
Financial income, net | 10,864 | 860 | 6,690 |
Income before income taxes | 39,992 | 41,261 | 88,188 |
Income tax expense | (4,208) | (3,700) | (8,239) |
Net income | $ 35,784 | $ 37,561 | $ 79,949 |
Net income per ordinary share: | |||
Basic net earnings per share | $ 0.8 | $ 0.86 | $ 1.81 |
Diluted net earnings per share | $ 0.74 | $ 0.78 | $ 1.66 |
Weighted average number of ordinary shares outstanding (in thousands): | |||
Basic | 44,562 | 43,929 | 44,158 |
Diluted | 48,531 | 48,150 | 48,229 |
Interim Unaudited Condensed Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands |
Ordinary Shares NIS 0.01 par value [Member] |
Treasury Shares [Member] |
Additional paid-in earnings [Member] |
Retained earnings [Member] |
Total |
|||
---|---|---|---|---|---|---|---|---|
Balance, value at Dec. 31, 2021 | $ 172 | $ (1,898) | $ 176,582 | $ 118,771 | $ 293,627 | |||
Balance, shares at Dec. 31, 2021 | 45,939,019 | (2,092,376) | ||||||
Share-based compensation expense | $ 0 | $ 0 | 5,592 | 0 | 5,592 | |||
Exercise of share options and RSUs | $ 2 | $ 0 | 0 | 0 | 2 | |||
Exercise of share options and RSUs, shares | 416,840 | 0 | ||||||
Net income | $ 0 | $ 0 | 0 | 37,561 | 37,561 | |||
Balance, value at Jun. 30, 2022 | $ 174 | $ (1,898) | 182,174 | 156,332 | 336,782 | |||
Balance, shares at Jun. 30, 2022 | 46,355,859 | (2,092,376) | ||||||
Balance, value at Dec. 31, 2021 | $ 172 | $ (1,898) | 176,582 | 118,771 | 293,627 | |||
Balance, shares at Dec. 31, 2021 | 45,939,019 | (2,092,376) | ||||||
Net income | 79,949 | |||||||
Balance, value at Dec. 31, 2022 | $ 175 | $ (1,898) | 187,105 | 198,720 | $ 384,102 | |||
Balance, shares at Dec. 31, 2022 | 46,505,318 | (2,092,376) | 44,412,942 | |||||
Balance, value at Jun. 30, 2022 | $ 174 | $ (1,898) | 182,174 | 156,332 | $ 336,782 | |||
Balance, shares at Jun. 30, 2022 | 46,355,859 | (2,092,376) | ||||||
Share-based compensation expense | $ 0 | $ 0 | 4,931 | 0 | 4,931 | |||
Exercise of share options and RSUs | $ 1 | $ 0 | 0 | 0 | 1 | |||
Exercise of share options and RSUs, shares | 149,459 | 0 | ||||||
Net income | $ 0 | $ 0 | 0 | 42,388 | 42,388 | |||
Balance, value at Dec. 31, 2022 | $ 175 | $ (1,898) | 187,105 | 198,720 | $ 384,102 | |||
Balance, shares at Dec. 31, 2022 | 46,505,318 | (2,092,376) | 44,412,942 | |||||
Share-based compensation expense | $ 0 | $ 0 | 6,521 | 0 | $ 6,521 | |||
Exercise of share options and RSUs | [1] | $ 0 | 0 | 0 | 0 | |||
Exercise of share options and RSUs, shares | 306,186 | 0 | ||||||
Net income | $ 0 | $ 0 | 0 | 35,784 | 35,784 | |||
Balance, value at Jun. 30, 2023 | $ 175 | $ (1,898) | $ 193,626 | $ 234,504 | $ 426,407 | |||
Balance, shares at Jun. 30, 2023 | 46,811,504 | (2,092,376) | 44,719,128 | |||||
|
Nature of Operations |
6 Months Ended | |||
---|---|---|---|---|
Jun. 30, 2023 | ||||
Nature of Operations [Abstract] | ||||
Nature of Operations |
Note 1 - Nature of Operations
|
Basis of Preparation |
6 Months Ended |
---|---|
Jun. 30, 2023 | |
Basis of Preparation [Abstract] | |
Basis of Preparation |
Note 2 - Basis of Preparation
A. Statement of compliance
Except as described below, the accounting policies applied in these interim financial statements are the same as those applied in the Company’s 2022 annual audited consolidated financial statement for the year ended December 31, 2022.
The accompanying unaudited condensed consolidated interim financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and do not include all of the information required for full annual financial statements. The unaudited condensed consolidated interim statements should be read in conjunction with the Company’s 2022 annual audited consolidated financial statements and footnotes, which were filed with the U.S. Securities and Exchange Commission as part of the Company’s Annual Report on Form 20-F for the year ended December 31, 2022.
In the opinion of management of the Company, the accompanying unaudited condensed financial statements contain all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of its financial position as of June 30, 2023, and its results of operations for the three months and nine months ended June 30, 2023, and 2022, and cash flows for the six months ended June 30, 2023, and 2022. The condensed balance sheet at December 31, 2022, was derived from audited annual financial statements but does not contain all of the footnote disclosures from the annual financial statements.
|
Shareholders' Equity |
6 Months Ended |
---|---|
Jun. 30, 2023 | |
Shareholders' Equity [Abstract] | |
Shareholders' Equity |
Note 3 - Shareholders’ Equity
A. General
The Company’s shares are traded on the NASDAQ Global Market under the symbol “CAMT”, and also listed and traded on the Tel-Aviv stock exchange
B. Changes in Stock Options and RSUs
The number of stock options exercised in the six-month period ended June 30, 2023, was 306,186.
In the first six months of 2023, 509,231 restricted share units (RSUs) were granted by the Company. The RSUs vest over a four-year period.
C. Share-based Compensation Expense
The total share-based compensation expense amounted to $6,521, $5,592, and $10,523 for the six-month periods ended June 30, 2023 and 2022 and the year ended December 31, 2022, respectively.
|
Supplementary Financial Statements Information |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Supplemantary Financial Statements Information [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Supplementary Financial Statements Information |
Note 4 - Supplementary Financial Statements Information
A. Cash and cash equivalents
The Company’s cash and cash equivalent balance at June 30, 2023 and December 31, 2022 is denominated in the following currencies:
Short-term deposits are bank deposits in US Dollars with terms at the investment date of 3-12 months with average annual interest rates of 5.05%.
B. Inventories
Inventories are presented in:
C. Other Current Assets
D. Property, Plant and Equipment, Net
E. Intangible Assets, Net
F. Other Current Liabilities
(1) Changes in the accrued warranty costs are as follows:
G. Convertible Notes
The Convertible Senior Notes consisted of the following:
As of June 30, 2023, the debt issuance costs of the Notes will be amortized over the remaining term of approximately 3.5 years.
The annual effective interest rate of the Notes is 0.56%. In the six-months ended June 30, 2023, $547 was recorded as amortization of debt issuance costs (In the year ended December 31, 2022 - $1,094).
As of June 30, 2023, the estimated fair value of the Notes, which the Company has classified as Level 2 financial instruments, is $179,154 (December 31, 2022 - $152,565). The estimated fair value was determined based on the quoted bid price of the Notes in an over-the-counter market on the last trading day of the reporting period.
As of June 30, 2023, the principal amount exceeded the if-converted value of the Notes by $20,846 (December 31, 2022, the principal amount exceeded the if-converted value of the Notes by $47,435).
|
Statements of Operations |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Statement Related Disclosures [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Statements of Operations |
Note 5 - Statements of Operations
B. Financial income (expenses), net
|
Subsequent Events |
6 Months Ended |
---|---|
Jun. 30, 2023 | |
Subsequent Events [Abstract] | |
Subsequent Events |
Note 6 – Subsequent Events
On September 18, 2023, the Company announced it has entered into an agreement to acquire the FRT Metrology business of FormFactor, Inc. The acquisition is expected to close during the fourth quarter of 2023, subject to the satisfaction of customary closing conditions. The purchase price is $100 million in cash, subject to customary purchase price adjustments.
|
Basis of Preparation (Policies) |
6 Months Ended |
---|---|
Jun. 30, 2023 | |
Basis of Preparation [Abstract] | |
Statement of compliance |
A. Statement of compliance
Except as described below, the accounting policies applied in these interim financial statements are the same as those applied in the Company’s 2022 annual audited consolidated financial statement for the year ended December 31, 2022.
The accompanying unaudited condensed consolidated interim financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and do not include all of the information required for full annual financial statements. The unaudited condensed consolidated interim statements should be read in conjunction with the Company’s 2022 annual audited consolidated financial statements and footnotes, which were filed with the U.S. Securities and Exchange Commission as part of the Company’s Annual Report on Form 20-F for the year ended December 31, 2022.
In the opinion of management of the Company, the accompanying unaudited condensed financial statements contain all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of its financial position as of June 30, 2023, and its results of operations for the three months and nine months ended June 30, 2023, and 2022, and cash flows for the six months ended June 30, 2023, and 2022. The condensed balance sheet at December 31, 2022, was derived from audited annual financial statements but does not contain all of the footnote disclosures from the annual financial statements.
|
Supplementary Financial Statements Information (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cash and Cash Equivalents [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Cash and cash equivalents |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Inventories |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Other Current Assets |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Property, Plant and Equipment, Net |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Intangible Assets, Net |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Other Current Liabilities |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of accrued warranty costs |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Scheduled of convertible senior notes |
|
Statements of Operations (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Statement Related Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Selected Selling, General and Administrative Expenses Data |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Selected Financial Income (Expenses) Data |
|
Nature of Operations (Narrative) (Details) |
Jun. 30, 2023 |
---|---|
Priortech Ltd [Member] | |
Schedule of Equity Method Investments [Line Items] | |
Ownership percentage | 21.50% |
Chroma Ate Inc [Member] | |
Schedule of Equity Method Investments [Line Items] | |
Ownership percentage | 17.50% |
Shareholders' Equity (Narrative) (Details) - USD ($) $ in Thousands |
6 Months Ended | 12 Months Ended | |
---|---|---|---|
Jun. 30, 2023 |
Jun. 30, 2022 |
Dec. 31, 2022 |
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Share based compensation expense | $ 6,521 | $ 5,592 | $ 10,523 |
Stock Option [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Number of stock options granted | 306,186 | ||
Restricted Stock Units (RSUs) [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Number of stock options granted | 509,231 | ||
Vesting period | 4 years |
Supplementary Financial Statements Information (Currencies) (Details) - USD ($) $ in Thousands |
Jun. 30, 2023 |
Dec. 31, 2022 |
---|---|---|
Cash and Cash Equivalents [Line Items] | ||
Cash and cash equivalents | $ 232,787 | $ 148,156 |
US Dollars [Member] | ||
Cash and Cash Equivalents [Line Items] | ||
Cash and cash equivalents | 226,172 | 139,644 |
New Israeli Shekels [Member] | ||
Cash and Cash Equivalents [Line Items] | ||
Cash and cash equivalents | 4,416 | 4,008 |
Other Currencies [Member] | ||
Cash and Cash Equivalents [Line Items] | ||
Cash and cash equivalents | $ 2,199 | $ 4,504 |
Supplementary Financial Statements Information (Inventories) (Details) - USD ($) $ in Thousands |
Jun. 30, 2023 |
Dec. 31, 2022 |
---|---|---|
Inventory Disclosure [Abstract] | ||
Components | $ 34,158 | $ 43,017 |
Work in process | 15,444 | 13,951 |
Finished products (including systems at customer locations not yet sold) | 18,730 | 13,930 |
Total inventories | 68,332 | 70,898 |
Current assets | 61,207 | 65,541 |
Long-term assets | $ 7,125 | $ 5,357 |
Supplementary Financial Statements Information (Other Current Assets) (Details) - USD ($) $ in Thousands |
Jun. 30, 2023 |
Dec. 31, 2022 |
---|---|---|
Current assets | ||
Interest receivable | $ 7,048 | $ 3,979 |
Prepaid expenses | 4,315 | 3,832 |
Due from Government institutions | 2,875 | 2,598 |
Other | 760 | 747 |
Other current assets | $ 14,998 | $ 11,156 |
Supplementary Financial Statements Information (Intangible Assets, Net) (Details) - USD ($) $ in Thousands |
Jun. 30, 2023 |
Dec. 31, 2022 |
---|---|---|
Goodwill and Intangible Assets Disclosure [Abstract] | ||
Patent registration costs | $ 2,195 | $ 2,135 |
Accumulated amortization and impairment | 1,593 | 1,538 |
Total intangible assets, net | $ 602 | $ 597 |
Supplementary Financial Statements Information (Other Current Liabilities) (Details) - USD ($) $ in Thousands |
Jun. 30, 2023 |
Dec. 31, 2022 |
Jun. 30, 2022 |
Dec. 31, 2021 |
---|---|---|---|---|
Accounts Payable and Accrued Liabilities, Current [Abstract] | ||||
Commissions | $ 18,789 | $ 18,048 | ||
Advances from customers and deferred revenues | 7,199 | 12,825 | ||
Accrued employee compensation and related benefits | 10,506 | 11,941 | ||
Accrued warranty costs | 3,041 | 3,161 | $ 3,161 | $ 3,265 |
Government institutions and income tax payable | 2,844 | 7,991 | ||
Accrued expenses | 1,884 | 1,570 | ||
Operating lease obligations | 1,266 | 1,297 | ||
Total other current liabilities | $ 45,529 | $ 56,833 |
Supplementary Financial Statements Information (Accrued warranty costs) (Details) - USD ($) $ in Thousands |
6 Months Ended | 12 Months Ended |
---|---|---|
Jun. 30, 2023 |
Dec. 31, 2022 |
|
Accounts Payable and Accrued Liabilities, Current [Abstract] | ||
Beginning of year | $ 3,161 | $ 3,265 |
Accruals | 2,721 | 5,823 |
Usage | (2,841) | (5,927) |
Balance at end of year | $ 3,041 | $ 3,161 |
Supplementary Financial Statements Information (Convertible Notes) (Details) - USD ($) $ in Thousands |
Jun. 30, 2023 |
Dec. 31, 2022 |
---|---|---|
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net [Abstract] | ||
Principle | $ 200,000 | $ 200,000 |
Unamortized issuance costs | 3,716 | 4,263 |
Net carrying amount | $ 196,284 | $ 195,737 |
Supplementary Financial Statements Information (Narrative) (Details) - USD ($) $ in Thousands |
6 Months Ended | 12 Months Ended | |
---|---|---|---|
Jun. 30, 2023 |
Jun. 30, 2022 |
Dec. 31, 2022 |
|
Debt Instrument [Line Items] | |||
Term of debt issuance costs amortization | 3 years 6 months | ||
Debt interest rate | 0.56% | ||
Amortization of debt issuance costs | $ 547 | $ 547 | $ 1,094 |
Estimated fair value of the notes classified as Level 2 financial instruments | 179,154 | 152,565 | |
Exceeded principal amount | $ 20,846 | $ 47,435 |
Statements of Operations (Selling, general and administrative expenses) (Details) - USD ($) $ in Thousands |
6 Months Ended | 12 Months Ended | |||
---|---|---|---|---|---|
Jun. 30, 2023 |
Jun. 30, 2022 |
Dec. 31, 2022 |
|||
Income Statement Related Disclosures [Abstract] | |||||
Selling | [1] | $ 17,910 | $ 18,840 | $ 38,249 | |
General and administrative | 6,127 | 5,611 | 11,250 | ||
Total selling, general and administrative expenses | 24,037 | 24,451 | 49,499 | ||
Shipping and handling costs | $ 1,025 | $ 980 | $ 2,294 | ||
|
Statements of Operations (Financial income (expenses), net) (Details) - USD ($) $ in Thousands |
6 Months Ended | 12 Months Ended | |||
---|---|---|---|---|---|
Jun. 30, 2023 |
Jun. 30, 2022 |
Dec. 31, 2022 |
|||
Income Statement Related Disclosures [Abstract] | |||||
Interest income | $ 11,838 | $ 2,488 | $ 8,648 | ||
Amortization of issuance costs of convertible notes | (547) | (547) | (1,094) | ||
Other, net | [1] | (427) | (1,081) | (864) | |
Financial income (expenses), net | 10,864 | 860 | 6,690 | ||
Foreign currency expense | $ (172) | $ 871 | $ (351) | ||
|
Subsequent Events (Narrative) (Details) $ in Millions |
1 Months Ended |
---|---|
Sep. 18, 2023
USD ($)
| |
Subsequent Event [Member] | FormFactor, Inc [Member] | |
Subsequent Event [Line Items] | |
Purchase price in cash | $ 100 |
1 Year Camtek Chart |
1 Month Camtek Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions